Company Overview
Century Extrusions Limited manufactures and sells aluminum extrusion products in India. It operates through two segments, Manufacturing of Aluminum Extruded Products; and Manufacturing of Transmission and Distribution Line. The company offers profiles and drawn products used in machinery, engineering systems, pump bodies, motor housings, process equipment, pneumatic components, valve bodies, and other industrial uses; aluminium sections for windows, doors, curtain walls, partitions, handrails, facades, and related building systems; transport and structural solutions for bus bodies, truck and trailer sections, and railway coach components; and products and fittings used in power transmission and distribution networks, including clamps, connectors, and related line hardware. It also supplies extruded and cold drawn round bars and hexagonal bars in straight lengths and cold drawn rods and wires in coil form for use in armour rods, detonator shell stock, lamp pin stock, metallising wire, rivet stock, and welding filler wire; and manufactures power transmission and distribution line hardware. In addition, the company offers aluminium extrusions, including standard sections and customised profiles for electrical busbars, building systems, automotive, and industrial applications. It markets its products under the Century brand. Century Extrusions Limited was incorporated in 1988 and is headquartered in Kolkata, India.
Why Investors Should Care
Return on capital employed stands at 28.0%.
Net profit has compounded at 22.5% per year over the last five years.
Trades at a P/E of 13.1, below the sector median of 20.9.
Recent Developments
- Mar 2026 Revenue of ₹478.56 Cr (+11.0% YoY); net profit ₹10.97 Cr.
- Trailing 12 Months Year-on-year growth — revenue +32.8%, earnings +56.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 8.8%, profit CAGR 22.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 8.76% |
| 1 Year: | 32.80% |
Compounded Profit Growth
| 5 Years: | 22.48% |
| 1 Year: | 56.70% |
Stock Price Performance
| 1 Year: | -16.10% |
| 6 Months: | -12.16% |
| 3 Months: | -2.43% |
| 1 Month: | -4.39% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- Death Cross7d ago
- RSI (14)48.11 · Neutral
P/E of 13.12 is below the sector median of 20.95 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 28.0%.
- Profit CAGR of 22.5% over 5 years.
CONS
- Trading 45.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CENTEXT Century Extrusions Limited NSEINFRA | 18.50 | 13.12 | ₹148.00 Cr | 0.00% | 28.04% | 13.23% | 8.76% | 22.48% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 10,958.00 | 37.77 | ₹3.22 L Cr | 2.25% | 11.84% | 10.66% | 11.92% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,220.00 | 12.04 | ₹2.98 L Cr | 0.58% | 18.75% | 22.30% | 3.61% | 75.28% |
| 4 | ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA | 2,284.80 | 45.45 | ₹2.19 L Cr | 1.19% | 24.41% | 20.24% | 1.10% | 1.75% |
| 5 | HINDZINC Hindustan Zinc Limited NSEINFRA | 518.00 | 12.82 | ₹2.19 L Cr | 2.07% | 61.97% | 61.13% | 5.61% | 9.58% |
| 6 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 172.33 | 19.47 | ₹2.15 L Cr | 2.33% | 11.32% | 10.56% | -1.59% | 7.21% |
| 7 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 885.60 | 12.01 | ₹1.97 L Cr | 0.56% | 9.42% | 9.80% | 7.10% | 9.87% |
| 8 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 2,894.40 | 34.52 | ₹1.96 L Cr | 0.35% | 3.98% | 4.80% | 14.30% | -10.06% |
| 9 | SOLARINDS Solar Industries India Limited NSEINFRA | 19,010.00 | 86.39 | ₹1.72 L Cr | 0.06% | 29.51% | 26.72% | 12.39% | 30.36% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 119.79 Cr | 104.15 Cr | 109.66 Cr | 122.53 Cr | 142.22 Cr |
| Cost of Revenue | - | 90.96 Cr | 78.36 Cr | 84.44 Cr | 95.46 Cr | 114.17 Cr |
| Gross Profit | - | 28.83 Cr | 25.79 Cr | 25.22 Cr | 27.07 Cr | 28.05 Cr |
| Operating Expenses | - | 23.08 Cr | 20.04 Cr | 18.66 Cr | 20.10 Cr | 21.44 Cr |
| Operating Income | - | 5.75 Cr | 5.75 Cr | 6.56 Cr | 6.97 Cr | 6.61 Cr |
| EBITDA | - | 6.95 Cr | 7.03 Cr | 7.70 Cr | 8.48 Cr | 8.49 Cr |
| Interest Expense | - | 2.91 Cr | 2.67 Cr | 3.02 Cr | 3.50 Cr | 1.54 Cr |
| Pretax Income | - | 3.28 Cr | 3.14 Cr | 3.57 Cr | 3.79 Cr | 4.61 Cr |
| Tax Provision | - | 61.00 L | 78.00 L | 81.00 L | 89.00 L | 1.66 Cr |
| Net Income | 2.45 Cr | 2.67 Cr | 2.36 Cr | 2.76 Cr | 2.90 Cr | 2.95 Cr |
| Diluted EPS | - | 0.33 | 0.30 | 0.35 | 0.36 | 0.37 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 372.01 Cr | 375.10 Cr | 431.25 Cr | 478.56 Cr |
| Cost of Revenue | - | 294.38 Cr | 293.10 Cr | 339.02 Cr | 378.89 Cr |
| Gross Profit | - | 77.63 Cr | 82.00 Cr | 92.23 Cr | 99.67 Cr |
| Operating Expenses | - | 58.96 Cr | 62.62 Cr | 69.75 Cr | 73.67 Cr |
| Operating Income | - | 18.67 Cr | 19.38 Cr | 22.48 Cr | 26.00 Cr |
| EBITDA | - | 18.98 Cr | 21.50 Cr | 25.29 Cr | 30.86 Cr |
| Interest Expense | - | 7.29 Cr | 7.26 Cr | 9.05 Cr | 9.89 Cr |
| Pretax Income | - | 8.64 Cr | 10.89 Cr | 12.81 Cr | 15.11 Cr |
| Tax Provision | - | 2.67 Cr | 3.44 Cr | 2.87 Cr | 4.14 Cr |
| Net Income | - | 5.97 Cr | 7.45 Cr | 9.94 Cr | 10.97 Cr |
| Diluted EPS | - | 0.75 | 0.93 | 1.24 | 1.37 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 132.90 Cr | 159.25 Cr | 170.83 Cr | 187.46 Cr |
| Current Assets | - | 100.82 Cr | 116.95 Cr | 113.29 Cr | 133.49 Cr |
| Cash & Equivalents | - | 8.06 Cr | 10.56 Cr | 10.06 Cr | 28.00 L |
| Inventory | - | 32.79 Cr | 39.63 Cr | 40.56 Cr | 68.16 Cr |
| Receivables | - | 34.19 Cr | 35.35 Cr | 35.44 Cr | 35.62 Cr |
| Total Liabilities | - | 67.75 Cr | 86.20 Cr | 87.86 Cr | 104.56 Cr |
| Current Liabilities | - | 59.91 Cr | 81.08 Cr | 83.10 Cr | 98.30 Cr |
| Long Term Debt | - | 7.11 Cr | 4.30 Cr | 1.86 Cr | 21.00 L |
| Total Debt | - | 47.73 Cr | 48.46 Cr | 51.92 Cr | 68.23 Cr |
| Total Equity | - | 65.15 Cr | 73.05 Cr | 82.97 Cr | 82.90 Cr |
| Shares Outstanding | - | 8.00 Cr | 8.00 Cr | 8.00 Cr | 8.00 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 13.70 Cr | 11.38 Cr | 13.31 Cr | 4.05 Cr |
| Investing Cash Flow | - | -52.00 L | -4.97 Cr | -6.16 Cr | -16.90 Cr |
| Financing Cash Flow | - | -5.39 Cr | -6.52 Cr | -7.65 Cr | 3.07 Cr |
| Capital Expenditure | - | -95.00 L | -5.39 Cr | -6.56 Cr | -17.55 Cr |
| Free Cash Flow | - | 12.75 Cr | 5.99 Cr | 6.75 Cr | -13.50 Cr |
| Net Change in Cash | - | 7.79 Cr | -11.00 L | -50.00 L | -9.78 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 20.9% | 21.9% | 21.4% | 20.8% |
| Operating Margin % | - | 5.0% | 5.2% | 5.2% | 5.4% |
| Net Margin % | - | 1.6% | 2.0% | 2.3% | 2.3% |
| ROE % | - | 9.2% | 10.2% | 12.0% | 13.2% |
| ROCE % | - | 25.6% | 24.8% | 25.6% | 29.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CENTEXT
Century Extrusions Ltd. - RE Share Price Live Today - CNBC TV18
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPWVRJRXpzMjhyQTVxbU83c2tSdnBWTGhOMDd6WHRQNUVqU3dMMERWdGQ3alVCSTNMcUhRY19iTW1sclpmcWZIbUc2SjU3T0VDOXJjZ1hZS3dLT0hzckpMNkpHOHFZWElfR193R1h1YmMzM1JqbGEyYzBLQ29paXI5cHM0ZEJLS2sx?oc=5"…
Context Therapeutics Decline Means Insider Profits Down To US$237k - Simply Wall Street
<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxOdmp4M05uU0psVEw5eVFwNDlseHNPYVpPNHJiRGFBOW55dVlMbk8xQnZCMHpCQ0V6YXUyNGtfUnFucjhTLUFGNmNidVpTbXFoN2dsOFAyQkJNTzZYMzdncjUtY2pIUWZONkZXQ3cyZkdmZEh6eVlZeUdqUWdJMFFSdlJQS2NVcWl4MGhmVE…
Century Extrusions CENTEXT Rights Issue Allotment October 2026 - Kalkine India
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxNbFF2M3hLbGJJT2VsLVVHNlc0UWZGQzZtQlR0REVKX3A4bEUxVE4zYlJMMG9YX2F3QW1Fd254cGhoZUtmOFU3Y0FpRkJIZ1dYUXpFemZTeTVGaDZLWkNrcU9kSTdYdlNUYUNEenJqamdqLTloZl9vV2N5SXU4aF9DQmVQYmxFd2VycFpUbk…
Century Extrusions Share Analyst Review 2026: Price Target and Outlook - Univest
<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE1RQ1RTRUxPUVprUmlIX1QtSFdrSVpyWWhrZjZUTEFwQ2h4OGdMR1pxTzBuem1oWWhxWGMtMU1xZVZkNEROX0VnWlJFd3dSQWFMTC1BMnI4MFpfaWFacmYycVNZaFRFRWhvSjdQY3NOekxLOHlWSjBUNQ?oc=5" target="_blank">Centu…
Context Therapeutics Stock Jumps Pre-Market On Analyst's Near 4x Upside View: Retail Pins High Hopes Too - Stocktwits
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNVGpzZVFUakE3bWpCc296LUxic25QcE83Qm5KUmN2Q0xpbmlDYnF1MF9Ra3o2THF4V2VaLWFvd1NzRUhjV2tUWUpoS1dkUWdwVzQ4amZIdndnd2k5TFBCT2sxeWxjQ2tYSnlSNEU3YzB2MkpCVklneEZ3aHlYdmtkYTFUMmhieWdRLVgzbU…
Context Therapeutics Inc. (CNTX) stock price, news, quote and history - Yahoo Finance UK
<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE93M241TFpjekRwRWpJeFZBeVFkaTBoMFJaTTRDaWU1NmNWRXU5MFlUdkY4RjhkR25sSURZRGhUb2lzQzRheE1RLVhPVlFwdnRvWmc?oc=5" target="_blank">Context Therapeutics Inc. (CNTX) stock price, news, quot…
CENTEXT — Frequently Asked Questions
What is the current share price of Century Extrusions Limited (CENTEXT)?
As of 2026-10-24 04:55 IST, Century Extrusions Limited (CENTEXT) trades at ₹18.50 on NSE. Its 52-week range is ₹16.52 to ₹33.95.
What is the market capitalisation of CENTEXT?
Century Extrusions Limited (CENTEXT) has a market capitalisation of ₹148.00 Cr on NSE.
What is the P/E ratio of CENTEXT?
CENTEXT trades at a trailing price-to-earnings (P/E) ratio of 13.12. The industry average P/E is 20.95. Its price-to-book (P/B) ratio is 1.72.
What is the return on equity (ROE) of CENTEXT?
CENTEXT has a return on equity (ROE) of 13.23%. Its return on capital employed (ROCE) is 28.04%.
Is CENTEXT a good stock to buy?
This page provides a data-driven analysis of Century Extrusions Limited (CENTEXT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.